Publications en collaboration avec des chercheurs de Massachusetts General Hospital (8)

2021

  1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial

    The Lancet Oncology, Vol. 21, Núm. 1, pp. 60-72

2019

  1. PIK3CA alterations and benefit with neratinib: Analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial

    Breast Cancer Research, Vol. 21, Núm. 1

2016

  1. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy

    European Journal of Cancer, Vol. 56, pp. 85-92

2015

  1. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

    European Journal of Cancer

  2. Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy

    Breast Cancer Research, Vol. 17, Núm. 1

2013

  1. Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial

    The Lancet Oncology, Vol. 14, Núm. 1, pp. 88-96

2012

  1. Cancer therapy-induced cardiac toxicity in early breast cancer addressing the unresolved issues

    Circulation, Vol. 126, Núm. 23, pp. 2749-2763